HK Stock MarketDetailed Quotes

01548 GENSCRIPT BIO

Watchlist
  • 10.440
  • -1.020-8.90%
Market Closed Apr 19 16:08 CST
22.17BMarket Cap-29743P/E (TTM)

GENSCRIPT BIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
34.17%839.53M
26.40%391.31M
27.67%625.7M
34.86%309.59M
25.39%490.1M
37.97%229.57M
42.98%390.85M
36.53%166.39M
18.33%273.35M
8.61%121.88M
Operating income
34.17%839.53M
26.40%391.31M
27.67%625.7M
34.86%309.59M
25.39%490.1M
37.97%229.57M
42.98%390.85M
36.53%166.39M
18.33%273.35M
8.61%121.88M
Cost of sales
-33.69%-429.98M
-53.28%-216.26M
-54.94%-321.62M
-55.13%-141.09M
-53.82%-207.58M
-56.21%-90.95M
-45.01%-134.95M
-35.46%-58.22M
-28.40%-93.06M
-39.29%-42.98M
Operating expenses
-33.69%-429.98M
-53.28%-216.26M
-54.94%-321.62M
-55.13%-141.09M
-53.82%-207.58M
-56.21%-90.95M
-45.01%-134.95M
-35.46%-58.22M
-28.40%-93.06M
-39.29%-42.98M
Gross profit
34.68%409.55M
3.89%175.05M
7.63%304.08M
21.55%168.5M
10.40%282.52M
28.15%138.62M
41.93%255.89M
37.10%108.17M
13.72%180.29M
-3.03%78.9M
Selling expenses
-3.53%-174.3M
6.37%-81.4M
-0.23%-168.35M
-49.21%-86.94M
-56.48%-167.97M
-41.92%-58.27M
-52.56%-107.34M
-32.62%-41.06M
-81.47%-70.36M
-63.04%-30.96M
Administrative expenses
-16.98%-213.44M
-33.73%-106.52M
-35.65%-182.46M
-41.44%-79.65M
-48.89%-134.51M
-54.85%-56.31M
-63.50%-90.34M
-38.98%-36.37M
-36.16%-55.26M
-36.39%-26.17M
Research and development expenses
-10.95%-432.83M
-16.74%-207.33M
-8.84%-390.1M
-1.41%-177.61M
-36.07%-358.4M
-51.69%-175.13M
-41.60%-263.4M
-83.73%-115.45M
-151.12%-186.02M
-125.48%-62.84M
Revaluation surplus
131.54%43.46M
24.21%-34.73M
113.46%18.77M
-2,764.00%-45.82M
-74.32%-139.43M
98.00%-1.6M
---79.98M
---79.98M
----
----
-Changes in the fair value of other assets
131.54%43.46M
24.21%-34.73M
113.46%18.77M
-2,764.00%-45.82M
-74.32%-139.43M
98.00%-1.6M
---79.98M
---79.98M
----
----
Impairment and provision
-30.15%-16.44M
-54.20%-2.37M
---12.63M
-24.70%-1.54M
----
---1.23M
----
----
----
----
-Other impairment is provision
-30.15%-16.44M
-54.20%-2.37M
---12.63M
-24.70%-1.54M
----
---1.23M
----
----
----
----
Operating interest expense
----
-277.32%-12.46M
----
---3.3M
56.22%-2.38M
----
-595.52%-5.43M
-1,065.37%-4.51M
---781K
---387K
Special items of operating profit
393.55%60.52M
841.80%25.34M
189.29%12.26M
-170.55%-3.42M
-54.41%4.24M
-56.10%4.84M
-54.86%9.3M
99.46%11.03M
9.44%20.6M
28.10%5.53M
Operating profit
22.69%-323.47M
-6.37%-244.42M
18.90%-418.42M
-54.13%-229.78M
-83.40%-515.93M
5.74%-149.08M
-152.22%-281.31M
-340.32%-158.17M
-585.91%-111.53M
-282.90%-35.92M
Financing cost
-107.33%-27.51M
----
---13.27M
----
----
---1.14M
----
----
----
----
Share of profits of associates
----
---230K
----
----
----
----
-94.48%-599K
-125.90%-314K
-53.23%-308K
-434.62%-139K
Special items of earning before tax
----
----
----
----
-20,614.29%-1.44M
----
100.38%7K
177.46%433K
---1.85M
---559K
Earning before tax
18.70%-350.98M
-6.47%-244.65M
16.56%-431.69M
-52.96%-229.78M
-83.53%-517.36M
4.95%-150.22M
-147.95%-281.9M
-331.60%-158.05M
-600.84%-113.69M
-286.83%-36.62M
Tax
-211.37%-4.14M
71.05%-1.1M
485.79%3.72M
35.65%-3.81M
-302.10%-964K
-140.66%-5.93M
112.47%477K
-174.97%-2.46M
-97.11%-3.83M
268.07%3.28M
After-tax profit from continuing operations
17.02%-355.12M
-5.21%-245.76M
17.43%-427.97M
-49.59%-233.59M
-84.18%-518.33M
2.72%-156.15M
-139.48%-281.42M
-381.50%-160.51M
-666.10%-117.52M
-288.91%-33.34M
Earning after tax
17.02%-355.12M
-5.21%-245.76M
17.43%-427.97M
-49.59%-233.59M
-84.18%-518.33M
2.72%-156.15M
-139.48%-281.42M
-381.50%-160.51M
-666.10%-117.52M
-288.91%-33.34M
Minority profit
-29.10%-259.64M
-55.15%-152.18M
-26.00%-201.12M
-50.83%-98.08M
-108.71%-159.62M
-37.14%-65.03M
-271.18%-76.48M
-691.73%-47.42M
-4,408.53%-20.6M
-381.57%-5.99M
Profit attributable to shareholders
57.91%-95.48M
30.94%-93.58M
36.76%-226.85M
-48.71%-135.51M
-75.03%-358.71M
19.43%-91.12M
-111.48%-204.95M
-313.56%-113.09M
-556.79%-96.91M
-276.21%-27.35M
Basic earnings per share
58.13%-0.0453
31.48%-0.0444
38.77%-0.1082
-40.56%-0.0648
-63.91%-0.1767
23.29%-0.0461
-106.12%-0.1078
-306.08%-0.0601
-543.22%-0.0523
-266.29%-0.0148
Diluted earnings per share
58.13%-0.0453
31.48%-0.0444
38.77%-0.1082
-40.56%-0.0648
-63.91%-0.1767
23.29%-0.0461
-106.12%-0.1078
-306.08%-0.0601
-554.78%-0.0523
-274.12%-0.0148
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 34.17%839.53M26.40%391.31M27.67%625.7M34.86%309.59M25.39%490.1M37.97%229.57M42.98%390.85M36.53%166.39M18.33%273.35M8.61%121.88M
Operating income 34.17%839.53M26.40%391.31M27.67%625.7M34.86%309.59M25.39%490.1M37.97%229.57M42.98%390.85M36.53%166.39M18.33%273.35M8.61%121.88M
Cost of sales -33.69%-429.98M-53.28%-216.26M-54.94%-321.62M-55.13%-141.09M-53.82%-207.58M-56.21%-90.95M-45.01%-134.95M-35.46%-58.22M-28.40%-93.06M-39.29%-42.98M
Operating expenses -33.69%-429.98M-53.28%-216.26M-54.94%-321.62M-55.13%-141.09M-53.82%-207.58M-56.21%-90.95M-45.01%-134.95M-35.46%-58.22M-28.40%-93.06M-39.29%-42.98M
Gross profit 34.68%409.55M3.89%175.05M7.63%304.08M21.55%168.5M10.40%282.52M28.15%138.62M41.93%255.89M37.10%108.17M13.72%180.29M-3.03%78.9M
Selling expenses -3.53%-174.3M6.37%-81.4M-0.23%-168.35M-49.21%-86.94M-56.48%-167.97M-41.92%-58.27M-52.56%-107.34M-32.62%-41.06M-81.47%-70.36M-63.04%-30.96M
Administrative expenses -16.98%-213.44M-33.73%-106.52M-35.65%-182.46M-41.44%-79.65M-48.89%-134.51M-54.85%-56.31M-63.50%-90.34M-38.98%-36.37M-36.16%-55.26M-36.39%-26.17M
Research and development expenses -10.95%-432.83M-16.74%-207.33M-8.84%-390.1M-1.41%-177.61M-36.07%-358.4M-51.69%-175.13M-41.60%-263.4M-83.73%-115.45M-151.12%-186.02M-125.48%-62.84M
Revaluation surplus 131.54%43.46M24.21%-34.73M113.46%18.77M-2,764.00%-45.82M-74.32%-139.43M98.00%-1.6M---79.98M---79.98M--------
-Changes in the fair value of other assets 131.54%43.46M24.21%-34.73M113.46%18.77M-2,764.00%-45.82M-74.32%-139.43M98.00%-1.6M---79.98M---79.98M--------
Impairment and provision -30.15%-16.44M-54.20%-2.37M---12.63M-24.70%-1.54M-------1.23M----------------
-Other impairment is provision -30.15%-16.44M-54.20%-2.37M---12.63M-24.70%-1.54M-------1.23M----------------
Operating interest expense -----277.32%-12.46M-------3.3M56.22%-2.38M-----595.52%-5.43M-1,065.37%-4.51M---781K---387K
Special items of operating profit 393.55%60.52M841.80%25.34M189.29%12.26M-170.55%-3.42M-54.41%4.24M-56.10%4.84M-54.86%9.3M99.46%11.03M9.44%20.6M28.10%5.53M
Operating profit 22.69%-323.47M-6.37%-244.42M18.90%-418.42M-54.13%-229.78M-83.40%-515.93M5.74%-149.08M-152.22%-281.31M-340.32%-158.17M-585.91%-111.53M-282.90%-35.92M
Financing cost -107.33%-27.51M-------13.27M-----------1.14M----------------
Share of profits of associates -------230K-----------------94.48%-599K-125.90%-314K-53.23%-308K-434.62%-139K
Special items of earning before tax -----------------20,614.29%-1.44M----100.38%7K177.46%433K---1.85M---559K
Earning before tax 18.70%-350.98M-6.47%-244.65M16.56%-431.69M-52.96%-229.78M-83.53%-517.36M4.95%-150.22M-147.95%-281.9M-331.60%-158.05M-600.84%-113.69M-286.83%-36.62M
Tax -211.37%-4.14M71.05%-1.1M485.79%3.72M35.65%-3.81M-302.10%-964K-140.66%-5.93M112.47%477K-174.97%-2.46M-97.11%-3.83M268.07%3.28M
After-tax profit from continuing operations 17.02%-355.12M-5.21%-245.76M17.43%-427.97M-49.59%-233.59M-84.18%-518.33M2.72%-156.15M-139.48%-281.42M-381.50%-160.51M-666.10%-117.52M-288.91%-33.34M
Earning after tax 17.02%-355.12M-5.21%-245.76M17.43%-427.97M-49.59%-233.59M-84.18%-518.33M2.72%-156.15M-139.48%-281.42M-381.50%-160.51M-666.10%-117.52M-288.91%-33.34M
Minority profit -29.10%-259.64M-55.15%-152.18M-26.00%-201.12M-50.83%-98.08M-108.71%-159.62M-37.14%-65.03M-271.18%-76.48M-691.73%-47.42M-4,408.53%-20.6M-381.57%-5.99M
Profit attributable to shareholders 57.91%-95.48M30.94%-93.58M36.76%-226.85M-48.71%-135.51M-75.03%-358.71M19.43%-91.12M-111.48%-204.95M-313.56%-113.09M-556.79%-96.91M-276.21%-27.35M
Basic earnings per share 58.13%-0.045331.48%-0.044438.77%-0.1082-40.56%-0.0648-63.91%-0.176723.29%-0.0461-106.12%-0.1078-306.08%-0.0601-543.22%-0.0523-266.29%-0.0148
Diluted earnings per share 58.13%-0.045331.48%-0.044438.77%-0.1082-40.56%-0.0648-63.91%-0.176723.29%-0.0461-106.12%-0.1078-306.08%-0.0601-554.78%-0.0523-274.12%-0.0148
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg